Psychological intervention to improve the mental health of patients with COVID-19

The effect of cognitive behavioural therapy on depression, anxiety and stress in patients with COVID-19: a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN68675756

Enrollment

Registered

2020-07-01

Start date

2020-02-10

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, anxiety and stress in patients with COVID-19 (SARS-CoV-2 infection) Mental and Behavioural Disorders

Interventions

Ninety-three eligible participants selected by cluster sampling are randomized to an intervention group (n = 47) and a control group (n = 46) using a computerized random number generator by a trial st

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with COVID-19 who had mild symptoms in line with the diagnostic criteria of the Chinese Management Guidelines for COVID-19 (version 6.0) 2. Good communication and understanding of Chinese 3. Aged 20-69 years

Exclusion criteria

Exclusion criteria: 1. Previously diagnosed with depression and currently taking medication 2. Prior cognitive dysfunction 3. Experienced another major stressful event (e.g. divorce, bereavement) in the past year

Design outcomes

Primary

Measure	Time frame
Psychological health level of the patient with COVID-19, assessed using the Chinese Version of Depression Anxiety and Stress Scale-21 (DASS-21) for all participants at baseline and post- intervention (1 day later)	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026